Bicara Therapeutics (BCAX) Institutional Ownership

$20.00 +0.36 (+1.81%)

Closing price 03:58 PM Eastern

Extended Trading

$20.02 +0.02 (+0.10%)

As of 04:49 PM Eastern

Compare

Number of Institutional Buyers (last 12 months): 76
Total Institutional Inflows (last 12 months): $275.14M

Number of Institutional Sellers (last 12 months): 33
Total Institutional Outflows (last 12 months): $56.34M

Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2026	Bank of America Corp DE	327,989	$6.52M	0.0%	-2.3%	0.499%
5/19/2026	Janus Henderson Group PLC	3,339,218	$66.35M	0.0%	+26.2%	5.083%
5/18/2026	Rock Springs Capital Management LP	489,095	$9.73M	0.6%	+14.0%	0.744%
5/16/2026	The Manufacturers Life Insurance Company	90,285	$1.80M	0.0%	-8.7%	0.137%
5/16/2026	Quantinno Capital Management LP	17,612	$350K	0.0%	+16.1%	0.027%
5/16/2026	Orbimed Advisors LLC	667,300	$13.27M	0.2%	+219.1%	1.016%
5/14/2026	Siren L.L.C.	5,802,970	$115.42M	3.2%	+11.2%	8.833%
5/14/2026	Walleye Capital LLC	108,008	$2.15M	0.0%	N/A	0.164%
5/7/2026	Dimensional Fund Advisors LP	109,261	$2.17M	0.0%	+166.9%	0.167%
5/7/2026	Swiss National Bank	55,000	$1.09M	0.0%	+70.3%	0.084%
Get the Latest News and Ratings for BCAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/5/2026	Bank of New York Mellon Corp	83,264	$1.66M	0.0%	-6.1%	0.127%
5/1/2026	Candriam S.C.A.	238,822	$4.75M	0.0%	N/A	0.364%
3/3/2026	Caitong International Asset Management Co. Ltd	5,775	$97K	0.0%	+385.3%	0.011%
2/19/2026	T. Rowe Price Investment Management Inc.	3,236,595	$54.47M	0.0%	+596.5%	5.908%
2/19/2026	Invesco Ltd.	21,006	$354K	0.0%	+20.6%	0.038%
2/18/2026	XTX Topco Ltd	34,067	$573K	0.0%	-9.8%	0.062%
2/18/2026	VARCOV Co.	15,653	$263K	0.1%	N/A	0.029%
2/18/2026	Vestal Point Capital LP	3,575,000	$60.17M	2.0%	-29.9%	6.526%
2/18/2026	Virtus Investment Advisers LLC	14,395	$242K	0.1%	+46.4%	0.026%
2/18/2026	Tudor Investment Corp ET AL	27,391	$461K	0.0%	+46.2%	0.050%
2/18/2026	Orbimed Advisors LLC	209,100	$3.52M	0.1%	N/A	0.382%
2/18/2026	Millennium Management LLC	434,699	$7.32M	0.0%	-57.2%	0.794%
2/18/2026	Janus Henderson Group PLC	2,646,285	$44.48M	0.0%	N/A	4.831%
2/17/2026	Trexquant Investment LP	37,094	$624K	0.0%	-2.4%	0.068%
2/17/2026	FIL Ltd	758,493	$12.77M	0.0%	-5.6%	1.385%
2/17/2026	Jump Financial LLC	20,988	$353K	0.0%	N/A	0.038%
2/17/2026	Price T Rowe Associates Inc. MD	1,559,535	$26.25M	0.0%	-11.2%	2.847%
2/17/2026	T. Rowe Price Investment Management Inc.	165,243	$2.78M	0.0%	-64.4%	0.302%
2/17/2026	Rock Springs Capital Management LP	429,095	$7.22M	0.4%	+15.8%	0.783%
2/17/2026	California State Teachers Retirement System	17,158	$289K	0.0%	+701.4%	0.031%
2/17/2026	Russell Investments Group Ltd.	56,598	$953K	0.0%	+44.7%	0.103%
2/17/2026	Graham Capital Management L.P.	13,116	$221K	0.0%	N/A	0.024%
2/16/2026	Mariner LLC	64,562	$1.09M	0.0%	+3.0%	0.118%
2/16/2026	Barclays PLC	103,241	$1.74M	0.0%	+114.4%	0.188%
2/13/2026	The Manufacturers Life Insurance Company	98,918	$1.60M	0.0%	-22.0%	0.181%
2/13/2026	Hudson Bay Capital Management LP	150,000	$2.52M	0.0%	N/A	0.274%
2/13/2026	Rafferty Asset Management LLC	59,819	$1.01M	0.0%	N/A	0.109%
2/13/2026	Charles Schwab Investment Management Inc.	272,145	$4.58M	0.0%	-3.1%	0.497%
2/13/2026	State Street Corp	1,649,537	$27.76M	0.0%	+179.5%	3.011%
2/13/2026	Wells Fargo & Company MN	35,243	$593K	0.0%	+35.9%	0.064%
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today. Download your copy now.
2/12/2026	HRT Financial LP	50,147	$843K	0.0%	N/A	0.092%
2/12/2026	Dimensional Fund Advisors LP	40,934	$689K	0.0%	N/A	0.075%
2/12/2026	Ensign Peak Advisors Inc	401,444	$6.76M	0.0%	N/A	0.733%
2/12/2026	New York State Common Retirement Fund	7,500	$126K	0.0%	+87.5%	0.014%
2/12/2026	Alps Advisors Inc.	44,978	$757K	0.0%	+70.5%	0.082%
2/12/2026	Swiss National Bank	32,300	$544K	0.0%	N/A	0.059%
2/12/2026	Nuveen LLC	38,841	$654K	0.0%	-12.6%	0.071%
2/11/2026	Deutsche Bank AG	128,626	$2.17M	0.0%	+0.9%	0.235%
2/11/2026	Letko Brosseau & Associates Inc.	11,175	$188K	0.0%	N/A	0.020%
2/11/2026	Franklin Resources Inc.	1,620,025	$27.27M	0.0%	N/A	2.957%
2/11/2026	Clearbridge Investments LLC	298,762	$5.03M	0.0%	-7.9%	0.545%
2/10/2026	TD Asset Management Inc	244,626	$4.12M	0.0%	+32.2%	0.447%
2/10/2026	Goldman Sachs Group Inc.	552,331	$9.30M	0.0%	+137.3%	1.008%
2/10/2026	Norges Bank	42,889	$722K	0.0%	N/A	0.078%
2/9/2026	Geode Capital Management LLC	811,400	$13.66M	0.0%	-2.4%	1.481%
2/9/2026	Bleakley Financial Group LLC	29,182	$491K	0.0%	-4.3%	0.053%
2/6/2026	Atle Fund Management AB	111,363	$1.87M	0.6%	-45.3%	0.203%
2/4/2026	Nan Fung Trinity HK Ltd.	372,385	$6.27M	0.5%	-3.2%	0.680%
1/29/2026	UBS Group AG	192,191	$3.24M	0.0%	+97.4%	0.351%
1/29/2026	China Universal Asset Management Co. Ltd.	8,927	$150K	0.0%	N/A	0.016%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	2,662	$45K	0.0%	N/A	0.005%
1/12/2026	Avanza Fonder AB	5,039	$85K	0.0%	-46.2%	0.009%
1/9/2026	SG Americas Securities LLC	11,122	$187K	0.0%	N/A	0.020%
1/1/2026	JPMorgan Chase & Co.	24,935	$394K	0.0%	-9.2%	0.046%
1/1/2026	Tudor Investment Corp ET AL	18,730	$296K	0.0%	N/A	0.034%
12/9/2025	Tudor Investment Corp ET AL	18,730	$296K	0.0%	N/A	0.034%
12/1/2025	Cantor Fitzgerald L. P.	100,000	$1.58M	0.0%	N/A	0.183%
11/17/2025	XTX Topco Ltd	37,774	$596K	0.0%	+16.5%	0.069%
11/17/2025	Vestal Point Capital LP	5,100,000	$80.53M	3.6%	+2.0%	9.310%
11/17/2025	Mariner LLC	62,660	$989K	0.0%	+403.8%	0.114%
11/17/2025	Millennium Management LLC	1,014,892	$16.03M	0.0%	+37.0%	1.853%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	16,110	$254K	0.0%	-14.0%	0.029%
11/17/2025	Larson Financial Group LLC	3,949	$62K	0.0%	+1,015.5%	0.007%
11/17/2025	Jain Global LLC	26,179	$413K	0.0%	-77.8%	0.048%
11/17/2025	Cinctive Capital Management LP	41,849	$661K	0.0%	N/A	0.076%
11/17/2025	Cantor Fitzgerald L. P.	100,000	$1.58M	0.0%	N/A	0.183%
11/17/2025	Bank of America Corp DE	456,621	$7.21M	0.0%	+1.2%	0.834%
11/17/2025	Algert Global LLC	17,590	$278K	0.0%	N/A	0.032%
11/17/2025	Alliancebernstein L.P.	40,770	$644K	0.0%	-10.5%	0.074%
11/14/2025	Creative Planning	10,044	$159K	0.0%	N/A	0.018%
11/14/2025	Schonfeld Strategic Advisors LLC	504,085	$7.96M	0.0%	+91.8%	0.920%
11/14/2025	ADAR1 Capital Management LLC	13,705	$216K	0.0%	-40.1%	0.025%
11/14/2025	Two Sigma Investments LP	95,238	$1.50M	0.0%	-29.2%	0.174%
11/13/2025	UBS Group AG	97,362	$1.54M	0.0%	+11.1%	0.178%
11/13/2025	BNP Paribas Financial Markets	36,516	$577K	0.0%	+1,052.7%	0.067%
11/13/2025	Russell Investments Group Ltd.	39,126	$618K	0.0%	+42.4%	0.071%
11/13/2025	Schroder Investment Management Group	173,651	$2.74M	0.0%	-59.2%	0.317%
11/12/2025	Barclays PLC	48,148	$760K	0.0%	-16.0%	0.088%
11/12/2025	Orion Porfolio Solutions LLC	11,303	$178K	0.0%	N/A	0.021%
11/12/2025	Intech Investment Management LLC	14,038	$222K	0.0%	-49.3%	0.026%
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
11/10/2025	TD Asset Management Inc	184,982	$2.92M	0.0%	-17.6%	0.339%
11/10/2025	Bleakley Financial Group LLC	30,478	$481K	0.0%	N/A	0.056%
11/7/2025	Vanguard Group Inc.	2,200,925	$34.75M	0.0%	+9.8%	4.030%
11/7/2025	JPMorgan Chase & Co.	24,935	$394K	0.0%	-9.2%	0.046%
11/6/2025	Rhumbline Advisers	45,619	$720K	0.0%	-2.8%	0.084%
11/5/2025	Alps Advisors Inc.	26,378	$417K	0.0%	-10.3%	0.048%
11/4/2025	Atle Fund Management AB	203,755	$3.22M	1.3%	+38.3%	0.373%
11/4/2025	Nan Fung Trinity HK Ltd.	384,885	$6.08M	0.6%	+12.2%	0.705%
11/3/2025	New York State Common Retirement Fund	4,000	$63K	0.0%	-84.7%	0.007%
10/20/2025	Ascent Group LLC	13,930	$220K	0.0%	N/A	0.026%

BCAX Institutional Ownership - Frequently Asked Questions

During the previous two years, 125 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), Siren L.L.C. ($115.42M), Janus Henderson Group PLC ($66.35M), Vestal Point Capital LP ($60.17M), FMR LLC ($57.91M), Red Tree Management LLC ($55.23M), and T. Rowe Price Investment Management Inc. ($54.47M).Learn more on Bicara Therapeutics' institutional investors.

Of the 119 institutional investors that purchased Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), Vestal Point Capital LP ($5.10M), Janus Henderson Group PLC ($4.53M), Red Tree Management LLC ($3.17M), T. Rowe Price Investment Management Inc. ($2.77M), FMR LLC ($2.27M), and Braidwell LP ($2.16M).

Institutional investors have bought a total of 18,098,956 shares in the last 24 months. This purchase volume represents approximately $275.14M in transactions.

Of the 33 institutional investors that sold Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vestal Point Capital LP ($1.53M), Millennium Management LLC ($580.19K), T. Rowe Price Investment Management Inc. ($299.48K), Schroder Investment Management Group ($251.69K), Price T Rowe Associates Inc. MD ($195.88K), Atle Fund Management AB ($92.39K), and Jain Global LLC ($91.73K).

Institutional investors have sold a total of 3,382,668 shares in the last 24 months. This volume of shares sold represents approximately $56.34M in transactions.

Related Companies

This page (NASDAQ:BCAX) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bicara Therapeutics (BCAX) Institutional Ownership

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

BCAX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bicara Therapeutics (BCAX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

BCAX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCAX shares?

Which institutional investors have been buying Bicara Therapeutics' stock?

How much institutional buying is happening at Bicara Therapeutics?

Which of Bicara Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Bicara Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools